Hemostasis and Thrombosis

Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.- Preanalytical Variables in Hemostasis Testing.- Automation in the Thrombosis and Hemostasis Laboratory.- Ultracentrifugation for Coagulation Testing.- Harmonization of Hemostasis Testing Across a Large Laboratory Network: An Example from Australia.- Auto-Validation of Routine Coagulation/Hemostasis Assays with Reflex Testing of Abnormal Test Results.- Laboratory Testing of Hemostasis in Pregnancy: A Brief Overview.- Protocols for D-Dimer Measurements for Aid to Diagnosis or Exclusion of Venous Thromboembolism.- Performance and Interpretation of Clot Waveform Analysis.- Laboratory Evaluation of Thrombophilia.- Laboratory Testing for Activated Protein C Resistance (APCR): An Update.- Evaluation of Activated Protein C Resistance using Thrombin Generation Test.- Performance of Chromogenic Protein C(PC) Testing.- Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.- An Overview of Laboratory Testing for Antiphospholipid Antibodies.- Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test.- Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).- An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).- Antiphospholipid Antibody Testing for Anti-Cardiolipin and Anti-2Glycoprotein I Antibodies using Chemiluminescence-Based Panels.- Laboratory Testing for Non-Criteria Antiphospholipid Antibodies-Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT).- Laboratory Testing for Non-Criteria Antiphospholipid Antibodies: Antibodies Towards the Domain One of Beta2-Glycoprotein I (aDI).- An Overview of Heparin Monitoring with the Anti-Xa Assay.- Ecarin Based Methods for Measuring Thrombin Inhibitors.- Assays to Monitor Bivalirudin.- Monitoring of Anti-Platelet Therapy.- Heparin Induced Thrombotic Thrombocytopenia (HITT) and Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT): Similar by Different.- Functional Testing for Heparin Induced Thrombocytopenia using Whole Blood Multiplate Impedance Aggregometry.- Multiple Electrode Aggregometry (Multiplate): Functional Assay for Vaccine Induced (Immune) Thrombotic Thrombocytopenia (VITT).- Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.- Serotonin Release Assay: Functional Assay for Heparin and Vaccine Induced (Immune) Thrombotic Thrombocytopenia.- An Overview of Laboratory Testing for ADAMTS13.- Automated and Rapid ADAMTS13 Testing using Chemiluminescence: Utility for Identification or Exclusion of TTP and Beyond.- Identification of ADAMTS13Inhibitors in Acquired TTP.- ADAMTS13 Activity: Screening Test Protocol.- ADAMTS13 Activity Measurement by ELISA and Fluorescence Resonance Energy Transfer Assay.- ADAMTS13 Antibody and Inhibitor Assays.- A Review of Factor VIII and Factor IX Assay Methods for Monitoring Extended Half-Life Products in Haemophilia A and B.- Measuring Emicizumab Levels in the Hemostasis Laboratory.- Chromogenic Factor VIII Assay for Patients with Haemophilia A and On Emicizumab Therapy.- Assessment of Platelet Function by Automated Light Transmission Aggregometry.- Assessment of Platelet Function by High-Throughput Screening Light Transmittance Aggregometry: Optimul Assay.- Preparing Surrogate Abnormal Quality Samples for Platelet Function Studies and Viscoelastic Testing.- Laboratory Testing for von Willebrand Disease Using a Composite Rapid 3-Test Chemiluminescence-Based von Willebrand Factor Assay Panel.- Laboratory Testing for von Wilebrand Factor Activity by a Glycoproein Ib Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP®.- Laboratory Testing for von Willebrand Factor:Factor VIII Binding for Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.- Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement.- Measurement of Blood Viscoelasticity using Thromboelastography.- The TEG 5000© System: System Description and Protocol for Measurements.- The TEG 6s© System: System Description and Protocol for Measurements.- The Quantra® System: System Description and Protocols for Measurements.- Modified Rotational Thromboelastometry Protocol using Tissue Plasminogen Activator for Detection of Hypofibrinolysis and Hyperfibrinolysis.- Protocol for the Investigation of Plasma and Whole Blood Clot Property of Fibrin Fiber Thickness using Scanning Electron Microscopy.- Post-Analytical Issues in Hemostasis and ThrombosisTesting: An Update.